WBPaper00041174:genotypic

two-way ANOVA Genes with variation in expression level across genotypes (AB2, CB4856, RC301, CB4857, N2, HC445).

WBPaper00053909:N2_vs_CB4856_upregulated

DESeq2, fold change > 4. Transcripts that showed more than 4 fold of expression in N2 comparing to in CB4856 animals.

WBPaper00053909:N2_vs_CB4856_downregulated

DESeq2, fold change > 4. Transcripts that showed more than 4 fold of expression in CB4856 comparing to in N2 animals.

WBPaper00049325:CB4856_vs_N2_DEG

To identify proteins that are differentially expressed between N2 and CB4856, SILAC data were filtered for proteins that were quantified at least twice with at least a 1.3-fold difference in abundance and a p-value < 0.000457 (z-test, permutation determined threshold with the FDR cutoff of 0.05). Proteins that showed differential expression between CB4856 and N2 animals.

WBPaper00062456:doxycycline_downregulated_CB4856_protein

edgeR (version 3.24.3), fold change > 2, FDR < 0.05. Proteins that showed significantly decreased expression in CB4856 animals growing in 15mg per mL doxycycline from L1 to L4 larva stage.

WBPaper00062456:doxycycline_downregulated_CB4856_transcript

edgeR (version 3.24.3), fold change > 4, FDR < 0.01. Transcripts that showed significantly decreased expression in CB4856 animals growing in 15mg per mL doxycycline from L1 to L4 larva stage.

WBPaper00041174:genotypic_prime

two-way ANOVA Genes with significant variation in expression level only across genotypes(AB2, CB4856, RC301, CB4857, N2, HC445), but not environments (control, 25C, High-pH-Salt, Liquid, infection).

WBPaper00062456:doxycycline_upregulated_CB4856_protein

edgeR (version 3.24.3), fold change > 2, FDR < 0.05. Proteins that showed significantly increased expression in CB4856 animals growing in 15mg per mL doxycycline from L1 to L4 larva stage.

WBPaper00062456:doxycycline_upregulated_CB4856_transcript

edgeR (version 3.24.3), fold change > 4, FDR < 0.01. Transcripts that showed significantly increased expression in CB4856 animals growing in 15mg per mL doxycycline from L1 to L4 larva stage.

WBPaper00041174:environmental_prime

two-way ANOVA Genes with significant variation in expression level only across environments(control, 25C, High-pH-Salt, Liquid, infection), but no genotypic variation (AB2, CB4856, RC301, CB4857, N2, HC445).